| Metric | Value ($ M) | Q1 FY25 |
|---|---|---|
| Revenue | 78.05 | 42.0% |
| Total Income | 78.05 | 42.0% |
| Expenditure | 82.83 | 30.7% |
| PBT | -2.97 | 68.6% |
| Net Profit | -2.97 | 68.6% |
| OPM | -6.13% | 9.15pp |
| NPM | -3.81% | 13.39pp |
| EPS | -0.05 | 95.7% |
Omada Health Reports Q1 2026 Results; Revenue Up 42% Y-o-Y
08 May 2026 · 8 May, 1:38 am
Summary
Omada Health reported a strong first quarter in 2026, with revenue reaching $78 million, a 42% increase year-over-year. The company's total membership grew to 1.02 million, up 51% from the previous year. Gross margin improved to 62%, and the net loss decreased to $3 million. For the year ending December 31, 2026, Omada expects revenue in the range of $322 million to $330 million, representing 25% growth compared with 2025.
Key Highlights
- 1
Omada Health's total membership reached 1.02 million at the end of Q1 2026, a 51% increase year-over-year.
- 2
First quarter revenue was $78 million, representing a 42% increase year-over-year.
- 3
Gross margin improved to 62% in the first quarter of 2026, up from 58% in Q1 2025.
- 4
Non-GAAP gross margin increased to 64% in the first quarter, compared to 60% in the prior year.
- 5
Net loss decreased to $3 million in the first quarter, an improvement from a $9 million net loss in Q1 2025.
- 6
Adjusted EBITDA was $1 million in the first quarter, compared to an adjusted EBITDA loss of $4 million in Q1 2025.
- 7
The company expects revenue in the range of $322 million to $330 million for the year ending December 31, 2026, representing 25% growth compared to 2025.
Management Comments
Sean Duffy
“Surpassing one million Total Members is a milestone that reflects the durable growth and operating leverage we’ve built over 15 years of earning trust with many of the nation’s leading employers, health plans, and PBMs. We’re proud to now have relationships with all three of the nation’s leading PBMs — including our newest collaboration with Optum Rx — giving us broad ability to meet employers wherever they are on their GLP-1 and cardiometabolic journey, and a platform we believe positions us to successfully meet our market opportunity in the years ahead.”
Informational and educational content only. Not investment advice.